Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/03/24 08:00:03 on US and Canada Markets.
2024-04-03 08:00:03 ET Scott Buck from H.C. Wainwright issued a price target of $2.50 for FPAY on 2024-04-03 06:07:00. The adjusted price target was set to $2.50. At the time of the announcement, FPAY was trading at $1.155. The overall price target consensus is at $4.00 ...
2024-04-03 08:00:03 ET Chris Caso from Wolfe Research issued a price target of $31.00 for INTC on 2024-04-03 06:04:00. The adjusted price target was set to $31.00. At the time of the announcement, INTC was trading at $43.94. The overall price target consensus is at $40.7...
2024-04-03 08:00:03 ET Ruben Roy from Stifel Nicolaus issued a price target of $45.00 for INTC on 2024-04-03 06:08:00. The adjusted price target was set to $45.00. At the time of the announcement, INTC was trading at $43.94. The overall price target consensus is at $40.7...
THE WOODLANDS, Texas, April 03, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced Jeff Wade, Lexicon’s president and chief financial officer, Tom Garner, Lexicon’s senior vice president and chief commercial officer, and Craig Granowitz, M.D., ...
NASHUA, N.H., April 03, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc . (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, is proud to announce a philanthropic global health collaboration with RAD-AID International . RAD-AID, a non-profit charitable organizat...
SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellu...
Kapoor becomes chair in addition to his current role as chief executive officer; Vikram Pandit to transition to lead independent director Vikas Bhalla and Vivek Jetley each promoted to president of EXL NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a leading data...
- Achievement of latest clinical candidate triggers additional $5 million milestone payment to CytomX and is the third milestone achieved in the collaboration to date - - CytomX-retains US co-commercialization and economic rights for select programs - SOUTH SAN FRANCISCO, Calif., ...
STOUGHTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a ...
DUBLIN, Ireland and BRIDGEWATER, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company received a Decision to Grant from the European Patent Office (EPO) for a new patent covering VAZKEPA ® (icosapent ethyl) that will extend VAZKEP...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
2.13%Change Percent:
Astellas Pharma Inc. ADR Company Name:
ALPMY Stock Symbol:
OTCMKTS Market: